Health related quality of life in sickle cell disease: Just scratching the surface

Pediatric Blood and Cancer

Volumn 54, Issue 1, 2010, Pages 1-2

  Bonner, Melanie J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL EVALUATION; CLINICAL TRIAL; COGNITION; CONCEPTUAL FRAMEWORK; DISEASE SEVERITY; HUMAN; LIFE EXPECTANCY; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSOCIAL DEVELOPMENT; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA; STROKE; HEALTH STATUS; NOTE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANEMIA, SICKLE CELL; HEALTH STATUS; HUMANS; QUALITY OF LIFE;

EID: 73349141421     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22301     Document Type: Review

References (15)

1. Varni JW, Seid M, Rode CA. The PedsQL: Measurement model for the Pediatric Quality of Life Inventory. Med Care 1999;37:126-139.
2. Panepinto JA, O'Mahar KM, DeBaun MR, et al. Health-related quality of life in children with sickle cell disease: Child and parent perception. Br J Haematol 2005;130:437-444.
3. Varni JW, Seid M, Knight TS, et al. The PedsQL 4.0 Generic Core Scales: Sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med 2002;25:175-193.
4. Varni JW, Seid M, Kurtin PS. The PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales in healthy and patient populations. Med Care 2001;39:800-812.
5. Landgraf JM, Abetz LN, Ware JE. The CHQ User's Manual, Boston, MA: HealthAct; 1999.
6. Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: A comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes 2007;16:43-57.
7. Panepinto JA, Pajewski NM, Foerster LM, et al. The performance of the PedsQL generic core scales in children with sickle cell disease. J Pediatr Hematol Oncol 2008;30:666-673.
8. Panepinto JA, O'Mahar KM, DeBaun MR, et al. Validity of the child health questionnaire for use in children with sickle cell disease. J Pediatr Hematol Oncol 2004;26:574-578.
9. Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFTextension study. Blood 2005;106:2269-2275.
10. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001;139:790-796.
11. Thornburg CD, Dixon N, Burgett S, et al. A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 2009;52:609-615.
12. Kinney TR, Helms RW,O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999;94:1550-1554.
13. Panepinto JA,Walters MC, Carreras J, et al. Matched-related donor transplantation for sickle cell disease: Report from the Center for International Blood and Transplant Research. Br J Haematol 2007;137:479-485.
14. Hoppe CC,Walters MC. Bone marrowtransplantation in sickle cell anemia. Curr Opin Oncol 2001;13:85-90.
15. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-2143.